Enhancing therapeutic outcomes with artificial intelligence for HR-positive, HER2-negative metastatic breast cancer.
- DOI
- 10.1016/j.ccell.2026.01.004
- Published
- 2026 Feb 9
- Container
- Cancer cell
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ccell.2026.01.004,
title = {Enhancing therapeutic outcomes with artificial intelligence for HR-positive, HER2-negative metastatic breast cancer.},
author = {Gomez Marti JL and Michaels E and Nasrazadani A and Wander SA and Brufsky AM},
year = {2026},
journal = {Cancer cell},
doi = {10.1016/j.ccell.2026.01.004},
url = {https://doi.org/10.1016/j.ccell.2026.01.004}
}RIS
TY - JOUR TI - Enhancing therapeutic outcomes with artificial intelligence for HR-positive, HER2-negative metastatic breast cancer. AU - Gomez Marti JL AU - Michaels E AU - Nasrazadani A AU - Wander SA AU - Brufsky AM PY - 2026 JO - Cancer cell DO - 10.1016/j.ccell.2026.01.004 UR - https://doi.org/10.1016/j.ccell.2026.01.004 ER -
APA
JL, G. M., E, M., A, N., SA, W., & AM, B. (2026). Enhancing therapeutic outcomes with artificial intelligence for HR-positive, HER2-negative metastatic breast cancer.. Cancer cell. https://doi.org/10.1016/j.ccell.2026.01.004
Source records
- pubmed · retrieved 2026-09-25T22:59:15.034Z